Enclosed is the presentation on the results for the quarter ended June 30, 2026

Filed: 20 Jul 2026, 20:32 IST Exchange: BSE Category: Financial Results — Investor Presentation

AI summary - Q1FY27 revenue grew 7% to Rs 1,022 Cr driven by domestic formulation volume growth - EBITDA rose 23% to Rs 184 Cr on volume growth and fixed cost optimization - PAT increased 31% to Rs 125 Cr - Crop Care B2C revenue up 19%, Soil & Plant Health revenue up 10%, B2B exports down 19% - Seeds revenue grew 6% despite delayed sowings; EBITDA +23%, PAT +30% - Launched 3 new Crop Care products and 9 seed products in Q1FY27 - Demand subdued due to delayed monsoon, crop shifts, and cotton acreage reduction - Digital marketing and aggressive placement aided volume growth - Focus on expanding portfolio, strategic alliances, and digital interventions

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 RALLIS — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add RALLIS to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Rallis India Limited

Important. The summary above is generated automatically from Rallis India Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.